Keay Nakae
Stock Analyst at Chardan Capital
(3.23)
# 2,381
Out of 4,377 analysts
593
Total ratings
38.2%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBIO iBio, Inc. | Reiterated: Buy | $5 | $1.82 | +174.73% | 6 | May 14, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $4 | $1.50 | +166.67% | 39 | May 12, 2026 | |
| SABS SAB Biotherapeutics | Reiterated: Buy | $14 | $3.38 | +314.20% | 19 | May 12, 2026 | |
| COYA Coya Therapeutics | Maintained: Buy | $14 | $4.42 | +216.74% | 19 | May 12, 2026 | |
| DYN Dyne Therapeutics | Maintained: Buy | $38 | $17.04 | +123.00% | 17 | May 11, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $80 → $90 | $73.09 | +23.14% | 46 | May 8, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $15 | $10.72 | +39.93% | 5 | May 7, 2026 | |
| SLN Silence Therapeutics | Maintained: Buy | $35 → $27 | $6.17 | +337.60% | 17 | May 7, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $425 | $303.05 | +40.24% | 51 | May 1, 2026 | |
| ANRO Alto Neuroscience | Maintained: Buy | $30 | $18.26 | +64.29% | 4 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥800 | $312.00 | +156.41% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €120.00 | $96.15 | +24.80% | 6 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $3.89 | +414.14% | 12 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $3 | $0.8708 | +244.51% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $0.715 | +5,494.41% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $30.01 | +16.63% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €10.00 → €5.00 | $0.91 | +449.45% | 5 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $85 | $59.78 | +42.19% | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $6 | $6.63 | n/a | 19 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.32 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.69 | n/a | 20 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.97 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $0.9065 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.5 → $5 | $4.25 | n/a | 47 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.70 | n/a | 7 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $0.3064 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 13 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.95 | n/a | 16 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.11 | n/a | 1 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.07 | n/a | 31 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.49 | n/a | 5 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.53 | n/a | 6 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.72 | n/a | 18 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.79 | n/a | 1 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $50 | $0.000001 | n/a | 8 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.92 | n/a | 15 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0837 | n/a | 2 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.19 | n/a | 15 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.35 | n/a | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,157.00 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.30 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.97 | n/a | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4.5 | $1.28 | n/a | 9 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.08 | n/a | 2 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $2 | $5.24 | n/a | 11 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $47.44 | n/a | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 2 | Jan 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.78 | n/a | 3 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.07 | n/a | 1 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.3 → $4.5 | $1.16 | n/a | 3 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.46 | n/a | 3 | Dec 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.38 | n/a | 1 | Aug 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 | $2.35 | n/a | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.25 → $2 | $0.000001 | n/a | 4 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $1.84 | n/a | 4 | Mar 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $1.63 | n/a | 1 | Dec 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $5.41 | n/a | 1 | Aug 6, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $18 | $0.0002 | n/a | 3 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $2.33 | n/a | 1 | Oct 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $0.000001 | n/a | 1 | Jul 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.3 | $0.2552 | n/a | 1 | Jun 25, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $36.30 | n/a | 1 | May 16, 2012 |
iBio, Inc.
May 14, 2026
Reiterated: Buy
Price Target: $5
Current: $1.82
Upside: +174.73%
ProQR Therapeutics
May 12, 2026
Reiterated: Buy
Price Target: $4
Current: $1.50
Upside: +166.67%
SAB Biotherapeutics
May 12, 2026
Reiterated: Buy
Price Target: $14
Current: $3.38
Upside: +314.20%
Coya Therapeutics
May 12, 2026
Maintained: Buy
Price Target: $14
Current: $4.42
Upside: +216.74%
Dyne Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $38
Current: $17.04
Upside: +123.00%
Arrowhead Pharmaceuticals
May 8, 2026
Reiterated: Buy
Price Target: $80 → $90
Current: $73.09
Upside: +23.14%
Korro Bio
May 7, 2026
Reiterated: Buy
Price Target: $15
Current: $10.72
Upside: +39.93%
Silence Therapeutics
May 7, 2026
Maintained: Buy
Price Target: $35 → $27
Current: $6.17
Upside: +337.60%
Alnylam Pharmaceuticals
May 1, 2026
Reiterated: Buy
Price Target: $425
Current: $303.05
Upside: +40.24%
Alto Neuroscience
Apr 21, 2026
Maintained: Buy
Price Target: $30
Current: $18.26
Upside: +64.29%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: ¥800
Current: $312.00
Upside: +156.41%
Mar 27, 2026
Maintained: Buy
Price Target: €120.00
Current: $96.15
Upside: +24.80%
Mar 12, 2026
Maintained: Buy
Price Target: $20
Current: $3.89
Upside: +414.14%
Feb 24, 2026
Upgraded: Buy
Price Target: $2.5 → $3
Current: $0.8708
Upside: +244.51%
Jan 5, 2026
Maintained: Buy
Price Target: $40
Current: $0.715
Upside: +5,494.41%
Jan 5, 2026
Maintained: Buy
Price Target: $35
Current: $30.01
Upside: +16.63%
Sep 30, 2025
Maintained: Buy
Price Target: €10.00 → €5.00
Current: $0.91
Upside: +449.45%
Sep 25, 2025
Maintained: Buy
Price Target: $60 → $85
Current: $59.78
Upside: +42.19%
May 8, 2025
Downgraded: Hold
Price Target: $25 → $6
Current: $6.63
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $12.32
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.69
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $2.97
Upside: n/a
Dec 20, 2024
Maintained: Hold
Price Target: $12
Current: $0.9065
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: $4.5 → $5
Current: $4.25
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $6
Current: $1.70
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $10 → $8
Current: $0.3064
Upside: n/a
Mar 14, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 12, 2023
Rated: Hold
Price Target: n/a
Current: $13.95
Upside: n/a
Mar 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $13.11
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $8.07
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $9.49
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $16.53
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.72
Upside: n/a
Feb 6, 2023
Reiterated: Buy
Price Target: n/a
Current: $9.79
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $100 → $50
Current: $0.000001
Upside: n/a
Sep 30, 2022
Rated: Hold
Price Target: n/a
Current: $2.92
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: n/a
Current: $0.0837
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.19
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $3.35
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $2,157.00
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $7.30
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $7.97
Upside: n/a
Jun 10, 2021
Reiterated: Hold
Price Target: $8 → $4.5
Current: $1.28
Upside: n/a
Nov 20, 2020
Rated: Hold
Price Target: n/a
Current: $1.08
Upside: n/a
Jul 30, 2020
Rated: Hold
Price Target: $2
Current: $5.24
Upside: n/a
Mar 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $47.44
Upside: n/a
Jan 28, 2020
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $15.78
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $15.07
Upside: n/a
Feb 16, 2017
Maintained: Buy
Price Target: $3.3 → $4.5
Current: $1.16
Upside: n/a
Dec 6, 2016
Maintained: Buy
Price Target: $6
Current: $2.46
Upside: n/a
Aug 23, 2016
Maintained: Buy
Price Target: $4
Current: $1.38
Upside: n/a
Aug 12, 2016
Reiterated: Buy
Price Target: $2.25
Current: $2.35
Upside: n/a
Jul 8, 2016
Maintained: Buy
Price Target: $2.25 → $2
Current: $0.000001
Upside: n/a
Mar 28, 2016
Reiterated: Buy
Price Target: $12 → $6
Current: $1.84
Upside: n/a
Dec 3, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $1.63
Upside: n/a
Aug 6, 2014
Downgraded: Hold
Price Target: $4
Current: $5.41
Upside: n/a
May 15, 2014
Downgraded: Hold
Price Target: $100 → $18
Current: $0.0002
Upside: n/a
Oct 7, 2013
Initiated Coverage: Buy
Price Target: $13
Current: $2.33
Upside: n/a
Jul 3, 2013
Reiterated: Buy
Price Target: $5.5
Current: $0.000001
Upside: n/a
Jun 25, 2013
Initiated Coverage: Buy
Price Target: $2.3
Current: $0.2552
Upside: n/a
May 16, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $36.30
Upside: n/a